Baird Medical Investment Holdings Limited (BDMD) Revenue History
Annual and quarterly revenue from 2019 to present
BDMD Revenue Over Time (2019–2025)
BDMD Revenue Growth History
4 of 6 years with positive growth- FY2019 revenue growth
- N/A
- FY2020 revenue growth
- +48.4%
- FY2021 revenue growth
- +53.0%
- FY2022 revenue growth
- +26.6%
- FY2023 revenue growth
- -10.4%
- FY2024 revenue growth
- +17.7%
- FY2025 revenue growth
- -39.2%
| Quarter | Revenue | YoY |
|---|---|---|
| Q4 2025 | $14.6M | -39.0% |
| Q2 2025 | $8.0M | -39.4% |
| Q4 2024 | $23.9M | — |
| Q2 2024 | $13.1M | +13.8% |
| Q2 2023 | $11.5M | — |
Revenue Breakdown
BDMD's revenue distribution by segment and geography
By Geography
BDMD Revenue Analysis (2019–2025)
Current Revenue & Growth
As of June 29, 2026, Baird Medical Investment Holdings Limited (BDMD) generated trailing twelve-month (TTM) revenue of $59.6 million, reflecting significant decline in growth of -39.0% year-over-year. The most recent quarter (Q4 2025) recorded $14.6 million in revenue, up 83.1% sequentially.
Historical Growth Trajectory
BDMD's 5-year compound annual growth rate (CAGR) stands at +4.5%, indicating moderate growth over time. The 3-year CAGR of -13.7% is below the 5-year average, signalling a growth deceleration in recent years. Baird Medical Investment Holdings Limited's highest annual revenue of $37.0 million was recorded in 2024.
Peer Comparison
Compared to Healthcare sector peers — including NVCR (+8.5% YoY), ARAY (-7.9% YoY), and AEYE (+11.6% YoY) — BDMD has underperformed the peer group in revenue growth. Compare BDMD vs NVCR →
BDMD Revenue vs Peers
Revenue metrics vs comparable public companies
| Company | TTM Revenue | YoY Growth | 5Y CAGR | Op. Margin | Compare |
|---|---|---|---|---|---|
| BDMDCurrent | $60M | -39.0% | +4.5% | -113.3% | |
 NVCR | $655M | +8.5% | +5.8% | -23.5% | |
 ARAY | $459M | -7.9% | +3.7% | 1.7% | |
 AEYE | $40M | +11.6% | +14.5% | -7.9% | |
 ELMD | $64M | +16.8% | +14.5% | 15.4% | |
 HLIT | $361M | -27.5% | -1.0% | 4.7% |
BDMD Historical Revenue Data (2019–2025)
| Year | Revenue | YoY % | Gross Profit | Gross Margin | Op. Income | Op. Margin |
|---|---|---|---|---|---|---|
| 2025 | $22.5M | -39.2% | $18.9M | 83.8% | $-25,537,411 | -113.3% |
| 2024 | $37.0M | +17.7% | $32.7M | 88.2% | $15.3M | 41.4% |
| 2023 | $31.5M | -10.4% | $27.2M | 86.6% | $11.9M | 37.7% |
| 2022 | $35.1M | +26.6% | $28.0M | 79.9% | $13.6M | 38.8% |
| 2021 | $27.7M | +53.0% | $23.2M | 83.6% | $11.9M | 43.0% |
| 2020 | $18.1M | +48.4% | $15.6M | 86.1% | $9.9M | 54.4% |
| 2019 | $12.2M | - | $10.9M | 89.4% | $5.6M | 45.9% |
Intrinsic Valuation
DCF models, multiple analysis, and analyst estimates.
Historical Returns
7+ years return with dividends reinvested.
DCA Calculator
See how regular investing compounds over time.
Peer Comparison
Compare growth, multiples, and margins vs sector.
BDMD — Frequently Asked Questions
Quick answers to the most common questions about buying BDMD stock.
Is BDMD's revenue growth accelerating or slowing?
BDMD revenue is declining -39.0% year-over-year. TTM revenue fell to $60M, contrasting with the 5-year CAGR of +4.5%. The reversal reflects either macro headwinds or company-specific challenges.
What is BDMD's revenue history from 2019 to 2026?
Baird Medical Investment Holdings Limited (BDMD) revenue history spans 2019 to 2026. TTM revenue as of 2026 is $60M, growing at -39.0% YoY. The 5-year CAGR is +4.5%. Complete annual and quarterly revenue figures are available on this page, including gross profit, operating income, and margin trends.
What is BDMD's long-term revenue growth rate (CAGR)?
Baird Medical Investment Holdings Limited's 5-year revenue CAGR of +4.5% reflects the variable nature of its business expansion. As of 2026, the current YoY growth rate of -39.0% is below this long-term average. CAGR is the most reliable measure of sustained revenue momentum for BDMD.
Why does BDMD's quarterly revenue fluctuate?
BDMD quarterly revenue can fluctuate significantly between periods. A quarter-over-quarter (QoQ) change does not always indicate a trend; comparing the same quarter year-over-year (YoY) is a more reliable signal for underlying growth. Baird Medical Investment Holdings Limited's revenue data from 2019 to 2026 shows full historical quarterly detail on this page.
How is BDMD's revenue distributed by segment?
BDMD reports revenue broken down by product line and geographic region. The segment breakdown on this page shows which business units contribute the most to total revenue as of the latest fiscal year. Concentration in a single segment above 50% indicates category dependence, while a diversified mix signals more resilient revenue streams.
How does BDMD's revenue compare to industry peers?
Baird Medical Investment Holdings Limited (BDMD) with TTM revenue of $60M and -39.0% YoY growth can be benchmarked against sector peers using the comparison table on this page. Revenue growth relative to peers indicates market share gains or losses. The peer section shows TTM revenue, YoY growth, and operating margin for direct comparisons.